Find clinical trials for Alzheimer's Disease in Los Angeles, CA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Alzheimer's Disease trials near Los Angeles, CA, USA:
designed to evaluate the efficacy, safety, and tolerability of two doses of CT1812 compared to placebo in participants diagnosed with early Alzheimer's...
Phase 2
Irvine, California, United States and 50 other locations
efficacy of investigational products in participants with an Alzheimer's disease-causing mutation by determining if treatment with ...
Phase 2, Phase 3
Los Angeles, California, United States and 37 other locations
To assess the safety, tolerability, biomarker, cognitive, and clinical efficacy of investigational products in participants with an Alzheimer's...
Phase 2, Phase 3
Los Angeles, California, United States and 35 other locations
This is a multicentre, randomized, double-blind, placebo-controlled, parallel group Phase II study to evaluate the efficacy and safety of VHB937 in p...
Phase 2
Los Angeles, California, United States and 71 other locations
This study is to test LHP588 in persons who have mild to moderate Alzheimer's disease (AD) who have shown progressive mental declin...
Phase 2
Sherman Oaks, California, United States and 38 other locations
This study will evaluate the efficacy and safety of trontinemab in participants with biomarker evidence of Alzheimer's Disease (AD)...
Phase 3
Santa Ana, California, United States of America and 6 other locations
Alzheimer's disease (AD) is a progressive, irreversible neurological disorder and is the most common cause of dementia in the elder...
Phase 1, Phase 2
Irvine, California, United States and 12 other locations
This 52-week, open-label extension study is to evaluate the long-term safety and tolerability of ACP-204 in subjects with ADP.
Phase 3
Garden Grove, California, United States and 76 other locations
and efficacy of ONO-2020 in participants with mild to moderate Alzheimer's disease (AD). This study aims to determine whether admin ...
Phase 2
Fullerton, California, United States of America and 82 other locations
The purpose of this study is to evaluate KarXT + KarX-EC as a treatment for psychosis associated with Alzheimer's disease....
Phase 3
Chino, California, United States and 21 other locations
Clinical trials
Research sites
Resources
Legal